Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01CJE
|
|||
| Drug Name |
4-(thiazol-5-yl)-pyrimidine derivative 2
|
|||
| Synonyms |
PMID26161698-Compound-36
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
CHANGZHOU LE SUN PHARMACEUTICALS LIMITED
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H15FN6O2S2
|
|||
| Canonical SMILES |
CC1=C(SC(=N1)NC)C2=NC(=NC=C2F)NC3=CC(=CC=C3)S(=O)(=O)N
|
|||
| InChI |
1S/C15H15FN6O2S2/c1-8-13(25-15(18-2)20-8)12-11(16)7-19-14(22-12)21-9-4-3-5-10(6-9)26(17,23)24/h3-7H,1-2H3,(H,18,20)(H2,17,23,24)(H,19,21,22)
|
|||
| InChIKey |
GAIOPWBQKZMUNO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.